SSDP Submits Commentary SR-17018 and research implications for the UK Parliament Secondary Legislation Scrutiny Committee
SSDP was invited to provide an expert comment by the Secondary Legislation Scrutiny Committee (SLSC) for UK Parliament in regards to an amendment to the UK “Misuse of Drugs Act 1971 Order 2026.”
The UK government is attempting to criminalize a new drug, SR-17018, before scientists can properly figure out how it works. This Act is similar to the US Controlled Substances Act where it places various substances into schedules or classes depending on their perceived level of harms.
Our fight to keep research legal doesn’t stop at our borders. Just this past July, we submitted a public comment challenging the U.S. DEA’s emergency scheduling of SR-17018, a research compound that shows promise for treatment of pain and opioid use disorder. Now, SSDP is speaking up to UK Parliament to demand that lawmakers base their decisions on solid scientific evidence rather than reflexively banning new chemical compounds.
The submission questions the evidence that justified the listing, and queries how, following the listing, SR-17018 could legitimately be used in research, particularly in developing treatments for opioid abuse. The full SLSC report on the above Order was published this morning in the top report at this link.
When we prohibit compounds there are real consequences:
- Research Red Tape: Legitimate scientists face costly licenses, security hurdles, and complex legal approvals. This often freezes research on promising compounds for years.
- Lost Therapeutic Opportunities: Blanket bans risk burying medical breakthroughs—like safer pain medications or novel treatments for opioid addiction—before researchers can prove their value.
- Precedent for Scientific Exemptions: SSDP is pushing for a policy shift: rather than using blanket bans on novel compounds, governments should leave open clear pathways for scientists to study them safely.
SSDP’s submission and the Government’s responses to questions arising from them, have also been published on the SLSC evidence page and is available to read below.
